Contact with the eyes, eyelids, mouth, lips, other mucous membranes and broken skin should be avoided. In case of accidental contact, rinse well with water. Care should be taken when applying the product to the neck and other sensitive areas.
This product contains propylene glycol alginate, stearyl alcohol and cetyl alcohol. Propylene glycol alginate may cause skin irritation. Stearyl alcohol and cetyl alcohol may cause local skin reaction (e.g. contact dermatitis).
During the first weeks of treatment, a sudden increase in peeling and reddening will occur in most patients and will normally subside in a day or two if treatment is temporarily discontinued.
Patients should be advised that excessive application will not improve efficacy, but may increase the risk of skin irritation.
Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy may occur, which sometimes may be severe, especially with the use of peeling, desquamating, or abrasive agents.
If severe, local irritancy occurs (e.g. severe erythema, severe dryness and itching, severe stinging/burning sensation), Brevoxyl should be discontinued.
As Brevoxyl may cause increased sensitivity to sunlight, sunlamps should not be used and deliberate or prolonged exposure to sunlight should be avoided or minimised. When exposure to strong sunlight cannot be avoided, patients should be advised to use a sunscreen product and wear protective clothing.
The product may bleach hair and coloured or dyed fabrics. Avoid contact with hair, fabrics, furniture or carpeting.